Main Industry
Health Care
Main Product/Service
Core Technologies: (1) Suture Design, Processing, and Development: medical device surface processing and modification technology platform, cutting and compression molding composite barb and patented technology, composite biomedical innovative suture formulation and development platform; (2) In vitro functional testing platform; (3) Suture clinical application development.
Main Product: Functional barbed medical sutures.
(The content above was translated by AI.)
Main Product: Functional barbed medical sutures.
(The content above was translated by AI.)
Founded Year
2023
Unified Business No.
94002847
Status
Active
Number of Employees
0
Total Paid-in
Capital
26,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
This team is led by Distinguished Professor Fang Hsu-Wei, Director of the Well-being and Health Industry Accelerator Center, a university-level R&D center of National Taipei University of Technology. Utilizing the patents for new suture materials and barbed manufacturing processes from Professor Fang's team, along with the capability of rapid commercialization processes, the team aims to resolve the six major pain points of current barbed medical sutures in Taiwan:
1. Developing new suture materials to produce long-lasting barbed medical sutures that stimulate collagen production.
2. Utilizing composite processing of cutting and molding to improve the mechanical properties of the barbs, enhancing grip strength and reducing discomfort caused by surface protrusions.
3. Designing diversified specifications to meet different lifting functional requirements.
4. Localizing the production of medical devices to remain unaffected by international situations.
5. Providing legal barbed medical sutures with lifting as the indicated use.
微科生醫股份有限公司 possesses an exceptionally strong independent R&D and rapid commercialization team for biomedical materials. Its core technologies include the development of long-lasting new suture materials, medical device surface processing and modification technologies, composite barb patents, and experience in the rapid integration of medical device commercialization. The company develops a brand-new generation of "innovative long-lasting barbed sutures" to effectively solve clinical pain points. Furthermore, by utilizing the unique in vitro barb testing platform established by the team, combined with the development of surgical techniques by clinicians, it constructs a comprehensive lifting strategy evaluation platform to provide all-around, effective solutions, thereby enhancing the output value and international competitiveness of Taiwan's high-end medical devices.
(The content above was translated by AI.)
1. Developing new suture materials to produce long-lasting barbed medical sutures that stimulate collagen production.
2. Utilizing composite processing of cutting and molding to improve the mechanical properties of the barbs, enhancing grip strength and reducing discomfort caused by surface protrusions.
3. Designing diversified specifications to meet different lifting functional requirements.
4. Localizing the production of medical devices to remain unaffected by international situations.
5. Providing legal barbed medical sutures with lifting as the indicated use.
微科生醫股份有限公司 possesses an exceptionally strong independent R&D and rapid commercialization team for biomedical materials. Its core technologies include the development of long-lasting new suture materials, medical device surface processing and modification technologies, composite barb patents, and experience in the rapid integration of medical device commercialization. The company develops a brand-new generation of "innovative long-lasting barbed sutures" to effectively solve clinical pain points. Furthermore, by utilizing the unique in vitro barb testing platform established by the team, combined with the development of surgical techniques by clinicians, it constructs a comprehensive lifting strategy evaluation platform to provide all-around, effective solutions, thereby enhancing the output value and international competitiveness of Taiwan's high-end medical devices.
(The content above was translated by AI.)
